Frovatriptan for prophylactic treatment of cluster headache: Lessons for future trial design

Headache

Volumn 51, Issue 1, 2011, Pages 129-134

  Pageler, Lutz ^a   Katsarava, Zaza ^b   Lampl, Christian ^c   Straube, Andreas ^d   Evers, Stefan ^e   Diener, Hans Christoph ^b   Limmroth, Volker ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c Konventhospital der Barmherzigen Bruder Linz   (Austria)

^d UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

cluster headache; frovatriptan; guidelines; prophylactic treatment; trial design

Indexed keywords

FROVATRIPTAN; PLACEBO;

ABSENCE OF SIDE EFFECTS; ARTICLE; CLINICAL ARTICLE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPISODIC CLUSTER HEADACHE; HUMAN; MEDICAL SOCIETY; MULTICENTER STUDY (TOPIC); PATIENT SELECTION; PHASE 3 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT COURSE THERAPY; STUDY DESIGN;

CARBAZOLES; CLUSTER HEADACHE; DOUBLE-BLIND METHOD; ENDPOINT DETERMINATION; GUIDELINES AS TOPIC; HUMANS; PATIENT SELECTION; RESEARCH DESIGN; SEROTONIN AGENTS; TRYPTAMINES;

EID: 78650949693     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2010.01772.x     Document Type: Article

References (16)

1. Cittadini E, May A, Straube A, Evers S, Bussone G, Goadsby PJ,. Effectiveness of intranasal zolmitriptan in acute cluster headache: A randomized, placebo-controlled, double-blind crossover study. Arch Neurol. 2006; 63: 1537-1542.
2. Fogan L,. Treatment of cluster headache. A double-blind comparison of oxygen v air inhalation. Arch Neurol. 1985; 42: 362-363.
3. Rapoport AM, Mathew NT, Silberstein SD, et al. Zolmitriptan nasal spray in the acute treatment of cluster headache: A double-blind study. Neurology. 2007; 69: 821-826.
4. The Sumatriptan Cluster Headache Study Group. Treatment of acute cluster headache with sumatriptan. N Engl J Med. 1991; 325: 322-326.
5. Gabai IJ, Spierings EL,. Prophylactic treatment of cluster headache with verapamil. Headache. 1989; 29: 167-168.
6. Leone M, D'Amico D, Frediani F, et al. Verapamil in the prophylaxis of episodic cluster headache: A double-blind study versus placebo. Neurology. 2000; 54: 1382-1385.
7. Ekbom K,. Lithium for cluster headache: Review of the literature and preliminary results of long-term treatment. Headache. 1981; 21: 132-139.
8. Steiner TJ, Hering R, Couturier EG, Davies PT, Whitmarsh TE,. Double-blind placebo-controlled trial of lithium in episodic cluster headache. Cephalalgia. 1997; 17: 673-675.
9. Mulder LJ, Spierings EL,. Naratriptan in the preventive treatment of cluster headache. Cephalalgia. 2002; 22: 815-817.
10. Zebenholzer K, Wober C, Vigl M, Wessely P,. Eletriptan for the short-term prophylaxis of cluster headache. Headache. 2004; 44: 361-364.
11. Siow HC, Pozo-Rosich P, Silberstein SD,. Frovatriptan for the treatment of cluster headaches. Cephalalgia. 2004; 24: 1045-1048.
12. Monstad I, Krabbe A, Micieli G, et al. Preemptive oral treatment with sumatriptan during a cluster period. Headache. 1995; 35: 607-613.
13. Tfelt-Hansen P, De Vries P, Saxena PR,. Triptans in migraine: A comparative review of pharmacology, pharmacokinetics and efficacy. Drugs. 2000; 60: 1259-1287.
14. Lipton RB, Micieli G, Russell D, Solomon S, Tfelt-Hansen P, Waldenlind E,. Guidelines for controlled trials of drugs in cluster headache. Cephalalgia. 1995; 15: 452-462.
15. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia. 2004; 24 (Suppl. 1): 9-160.
16. Bahra A, May A, Goadsby PJ,. Cluster headache: A prospective clinical study with diagnostic implications. Neurology. 2002; 58: 354-361.